NewzThis Wednesday, Argentina's National Administration of Drugs, Food and Medical Technology (ANMAT) ordered the preventive inhibition and the prohibition of use, commercialization, and distribution of all products from two laboratories, Trifarma S.R.L. and Ugal Farmacéu.
The regulatory action was taken due to detected irregularities in the quality control processes of the affected laboratories. These measures restrict the firms from operating and halt the availability of their pharmaceutical items in the market to ensure public health safety.
In-depth summary · AI, neutral